Last 12 months
Inside the activity.
2 purchase rows · 10 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 1 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 9 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 1 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 30, 2026 Filed Oct 2, 2026 01:19 UTC |
Bruns IngmarChief Medical Officer
|
GrantCommon Stock | 9,727 | $2.18 | $21,204.86 |
DisclosureSEC source: 0001628280-26-064317 · wk-form4_1790889591.xml · nonDerivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,059 F1 · kind: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the Issuer's 2020 Employee Stock Purchase Plan ("ESPP") for the ESPP purchase period of April 1, 2026 through September 30, 2026. This transaction is exempt under Rule 16b-3(c). F2 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on April 1, 2026. Read SEC document |
| August 14, 2026 Filed Aug 19, 2026 22:11 UTC |
WALTERS GROUP10% owner
WALTERS WILLIAM THURMAN10% owner
WALTERS SUSAN BERKLEY10% owner
|
PurchaseCommon Stock | 4,335,000 | $3.50 | $15,172,500.00 |
DisclosureSEC source: 0001213900-26-091823 · ownership.xml · nonDerivative · entry 1 WALTERS GROUP · CIK 0001177523 · 10% owner WALTERS WILLIAM THURMAN · CIK 0001689655 · 10% owner WALTERS SUSAN BERKLEY · CIK 0001689761 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,844,973 F1 · shares: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. F1 · balance_after: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. F1 · ownership.direct: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:09 UTC |
Johnson David MichaelDirector
|
GrantCommon Stock | 57,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001808098-26-000003 · wk-form4_1781813348.xml · nonDerivative · entry 1 Johnson David Michael · CIK 0001808098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 307,521 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:08 UTC |
Skvarka JanDirector
|
GrantCommon Stock | 57,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001838042-26-000003 · wk-form4_1781813319.xml · nonDerivative · entry 1 Skvarka Jan · CIK 0001838042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 264,254 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:07 UTC |
Kariuki EnochDirector
|
GrantCommon Stock | 57,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001843119-26-000003 · wk-form4_1781813217.xml · nonDerivative · entry 1 Kariuki Enoch · CIK 0001843119 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 194,465 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:07 UTC |
Walker Luke NathanielDirector
|
GrantCommon Stock | 57,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001701440-26-000004 · wk-form4_1781813274.xml · nonDerivative · entry 1 Walker Luke Nathaniel · CIK 0001701440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,384 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 16, 2026 Filed Jun 18, 2026 20:06 UTC |
Myers Scott DunsethDirector
|
GrantCommon Stock | 57,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001356256-26-000005 · wk-form4_1781813168.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 395,895 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 16, 2027 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| May 26, 2026 Filed May 27, 2026 20:11 UTC |
Campbell ShannonDirector
|
GrantCommon Stock | 114,200 | $0.00 | $0.00 |
DisclosureSEC source: 0002018966-26-000005 · wk-form4_1779912686.xml · nonDerivative · entry 1 Campbell Shannon · CIK 0002018966 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,200 F1 · balance_after: The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date. Read SEC document |
| February 10, 2026 Filed Feb 11, 2026 02:10 UTC |
Vultaggio VincentPAO and PFO
|
SaleCommon Stock | 6,894 | $2.42 | $16,699.34 |
DisclosureSEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 3 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 146,506 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 18, 2025. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 02:10 UTC |
Bruns IngmarChief Medical Officer
|
SaleCommon Stock | 335 | $2.39 | $801.62 |
DisclosureSEC source: 0001838041-26-000004 · wk-form4_1770775846.xml · nonDerivative · entry 2 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,332 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 02:10 UTC |
Vultaggio VincentPAO and PFO
|
SaleCommon Stock | 3,379 | $2.39 | $8,085.61 |
DisclosureSEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 2 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 153,400 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 09, 2026 Filed Feb 11, 2026 02:09 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
SaleCommon Stock | 889 | $2.39 | $2,127.29 |
DisclosureSEC source: 0001500189-26-000004 · wk-form4_1770775778.xml · nonDerivative · entry 2 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,133 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:10 UTC |
Bruns IngmarChief Medical Officer
|
SaleCommon Stock | 2,962 | $2.43 | $7,196.77 |
DisclosureSEC source: 0001838041-26-000004 · wk-form4_1770775846.xml · nonDerivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,667 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:10 UTC |
Vultaggio VincentPAO and PFO
|
SaleCommon Stock | 29,951 | $2.43 | $72,771.94 |
DisclosureSEC source: 0002018766-26-000006 · wk-form4_1770775823.xml · nonDerivative · entry 1 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 156,779 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 06, 2026 Filed Feb 11, 2026 02:09 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
SaleCommon Stock | 7,866 | $2.43 | $19,112.02 |
DisclosureSEC source: 0001500189-26-000004 · wk-form4_1770775778.xml · nonDerivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,022 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 03, 2026 Filed Feb 5, 2026 01:27 UTC |
Vultaggio VincentPAO and PFO
|
SaleCommon Stock | 556 | $2.52 | $1,398.34 |
DisclosureSEC source: 0002018766-26-000004 · wk-form4_1770254867.xml · nonDerivative · entry 2 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 186,730 F2 · shares: This sale was effected pursuant to a Rule 10b5-1 trading arrangement adopted by the Reporting Person. Read SEC document |
| February 02, 2026 Filed Feb 5, 2026 01:27 UTC |
Vultaggio VincentPAO and PFO
|
SaleCommon Stock | 2,540 | $2.55 | $6,477.00 |
DisclosureSEC source: 0002018766-26-000004 · wk-form4_1770254867.xml · nonDerivative · entry 1 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 187,286 F1 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 01:36 UTC |
Vultaggio VincentPAO and PFO
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.84 | $0.00 |
DisclosureSEC source: 0002018766-26-000002 · wk-form4_1768008966.xml · derivative · entry 1 Vultaggio Vincent · CIK 0002018766 · PAO and PFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Stock Option · 100,000 shares Expires 2036-01-07 F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 01:35 UTC |
Bucher James BChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.84 | $0.00 |
DisclosureSEC source: 0001664928-26-000003 · wk-form4_1768008932.xml · derivative · entry 1 Bucher James B · CIK 0001664928 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2036-01-07 F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 01:34 UTC |
Bruns IngmarChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 365,000 | $0.00 Strike: $2.84 | $0.00 |
DisclosureSEC source: 0001838041-26-000002 · wk-form4_1768008888.xml · derivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 365,000 Underlying: Common Stock · 365,000 shares Expires 2036-01-07 F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 08, 2026 Filed Jan 10, 2026 01:33 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 775,000 | $0.00 Strike: $2.84 | $0.00 |
DisclosureSEC source: 0001500189-26-000002 · wk-form4_1768008785.xml · derivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 775,000 Underlying: Common Stock · 775,000 shares Expires 2036-01-07 F1 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 31, 2025 Filed Jan 8, 2026 21:57 UTC |
WALTERS GROUP10% owner
WALTERS WILLIAM THURMAN10% owner
WALTERS SUSAN BERKLEY10% owner
|
PurchaseCommon Stock | 6,459,973 | $1.20 | $7,751,967.60 |
DisclosureSEC source: 0001213900-26-002567 · ownership.xml · nonDerivative · entry 1 WALTERS GROUP · CIK 0001177523 · 10% owner WALTERS WILLIAM THURMAN · CIK 0001689655 · 10% owner WALTERS SUSAN BERKLEY · CIK 0001689761 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,509,973 F1 · shares: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. F1 · balance_after: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. F1 · ownership.direct: The shares of common stock reported herein (the "Shares") are held directly by The Walters Group (the "TWG"). William T. Walters may be deemed to share voting and dispositive power with respect to the Shares. Susan B. Walters is the general partner and majority member of TWG and may be deemed to share voting and dispositive power with respect to the Shares. Each Reporting Person disclaims Section 16 beneficial ownership of the Shares reported herein except to the extent of its pecuniary interest therein, if any, and the inclusion of these Shares in this report shall not be deemed an admission of beneficial ownership of any of the reported Shares for purposes of Section 16 or any other purpose. Read SEC document |
| December 15, 2025 Filed Dec 15, 2025 22:24 UTC |
GOEL DAVID E.10% owner
|
SaleCommon Stock, par value $0.001 per share | 7,500,000 | $1.33 | $9,975,000.00 |
DisclosureSEC source: 0000902664-25-005288 · ownership.xml · nonDerivative · entry 1 Matrix Capital Management Company, LP · CIK 0001410830 · 10% owner GOEL DAVID E. · CIK 0001548144 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · See footnotes Disclosed balance after: 6,459,973 F1 · ownership.nature: The securities reported herein are held by Matrix Capital Management Master Fund, LP (the "Matrix Fund"). Matrix Capital Management Company, LP (the "Investment Manager"), a Delaware limited partnership, is the investment advisor to the Matrix Fund. Mr. David E. Goel ("Mr. Goel", and together with the Investment Manager, the "Reporting Persons"), serves as the Managing General Partner of the Investment Manager. F2 · ownership.nature: The filing of this statement shall not be deemed an admission that either of the Reporting Persons is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its or his pecuniary interest therein. Read SEC document |
| October 01, 2025 Filed Oct 1, 2025 22:40 UTC |
Bucher James BChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 400,000 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0001664928-25-000008 · wk-form4_1759358422.xml · derivative · entry 1 Bucher James B · CIK 0001664928 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2025-09-30 F1 · derivative.exercise_date: The options will vest over a four-year period as follows: 25% of the options will vest on October 1, 2026, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:15 UTC |
Johnson David MichaelDirector
|
GrantCommon Stock | 57,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000133 · wk-form4_1750277742.xml · nonDerivative · entry 1 Johnson David Michael · CIK 0001808098 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,421 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:19 UTC |
Walker Luke NathanielDirector
|
GrantCommon Stock | 57,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000137 · wk-form4_1750277940.xml · nonDerivative · entry 1 Walker Luke Nathaniel · CIK 0001701440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 144,284 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:17 UTC |
Skvarka JanDirector
|
GrantCommon Stock | 57,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000135 · wk-form4_1750277814.xml · nonDerivative · entry 1 Skvarka Jan · CIK 0001838042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 207,154 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:14 UTC |
Kariuki EnochDirector
|
GrantCommon Stock | 57,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000131 · wk-form4_1750277634.xml · nonDerivative · entry 1 Kariuki Enoch · CIK 0001843119 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 137,365 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| June 17, 2025 Filed Jun 18, 2025 20:12 UTC |
Myers Scott DunsethDirector
|
GrantCommon Stock | 57,603 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000129 · wk-form4_1750277537.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 338,795 F1 · shares: Represents restricted stock units granted pursuant to the Issuer's Non-Employee Director Compensation Program, each of which represents a contingent right to receive one share of common stock, and which will vest on the first to occur of (a) June 17, 2026 or (b) the next occurring annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors through such vesting date. Read SEC document |
| April 30, 2025 Filed Apr 30, 2025 21:07 UTC |
Myers Scott DunsethDirector
|
PurchaseCommon Stock | 21,000 | $1.40 | $29,372.70 |
DisclosureSEC source: 0001725160-25-000094 · wk-form4_1746047232.xml · nonDerivative · entry 1 Myers Scott Dunseth · CIK 0001356256 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 281,192 Read SEC document |
| February 06, 2025 Filed Feb 12, 2025 22:00 UTC |
Bruns IngmarChief Medical Officer
|
PurchaseCommon Stock | 20,000 | $2.28 | $45,656.00 |
DisclosureSEC source: 0001725160-25-000047 · wk-form4_1739397624.xml · nonDerivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,629 Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 18:31 UTC |
Paul AndreaChief Legal Officer
|
GrantStock Option (Right to Buy) · Derivative | 124,714 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · derivative · entry 3 Paul Andrea · CIK 0001863130 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,714 Underlying: Common Stock · 124,714 shares Expires 2035-02-02 F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 18:31 UTC |
Paul AndreaChief Legal Officer
|
SaleCommon Stock | 13,230 | $1.71 | $22,643.15 |
DisclosureSEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · nonDerivative · entry 2 Paul Andrea · CIK 0001863130 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,070,784 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 18:31 UTC |
Paul AndreaChief Legal Officer
|
GrantCommon Stock | 934,041 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000040 · wk-form4_1738798313.xml · nonDerivative · entry 1 Paul Andrea · CIK 0001863130 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,084,014 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:33 UTC |
Vultaggio VincentPAO and Interim PFO
|
GrantStock Option (Right to Buy) · Derivative | 35,633 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · derivative · entry 3 Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,633 Underlying: Common Stock · 35,633 shares Expires 2035-02-02 F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:33 UTC |
Vultaggio VincentPAO and Interim PFO
|
SaleCommon Stock | 2,615 | $1.71 | $4,475.57 |
DisclosureSEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · nonDerivative · entry 2 Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 189,826 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:33 UTC |
Vultaggio VincentPAO and Interim PFO
|
GrantCommon Stock | 158,586 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000043 · wk-form4_1738798376.xml · nonDerivative · entry 1 Vultaggio Vincent · CIK 0002018766 · PAO and Interim PFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 192,441 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:32 UTC |
Lackner MarkChief Scientific Officer
|
GrantStock Option (Right to Buy) · Derivative | 124,714 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · derivative · entry 3 Lackner Mark · CIK 0001777413 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 124,714 Underlying: Common Stock · 124,714 shares Expires 2035-02-02 F3 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:32 UTC |
Lackner MarkChief Scientific Officer
|
SaleCommon Stock | 14,368 | $1.71 | $24,590.83 |
DisclosureSEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · nonDerivative · entry 2 Lackner Mark · CIK 0001777413 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 512,856 F2 · shares: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:32 UTC |
Lackner MarkChief Scientific Officer
|
GrantCommon Stock | 335,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000041 · wk-form4_1738798344.xml · nonDerivative · entry 1 Lackner Mark · CIK 0001777413 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 527,224 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:29 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 59,388 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001725160-25-000036 · wk-form4_1738798191.xml · derivative · entry 2 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,388 Underlying: Common Stock · 59,388 shares Expires 2035-02-02 F2 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:29 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
GrantCommon Stock | 59,388 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000036 · wk-form4_1738798191.xml · nonDerivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 87,888 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:30 UTC |
Bruns IngmarChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 16,629 | $0.00 Strike: $1.68 | $0.00 |
DisclosureSEC source: 0001725160-25-000037 · wk-form4_1738798229.xml · derivative · entry 2 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,629 Underlying: Common Stock · 16,629 shares Expires 2035-02-02 F2 · derivative.exercise_date: The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 23:30 UTC |
Bruns IngmarChief Medical Officer
|
GrantCommon Stock | 16,629 | $0.00 | $0.00 |
DisclosureSEC source: 0001725160-25-000037 · wk-form4_1738798229.xml · nonDerivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,629 F1 · shares: Represents restricted stock units, each of which represent a contingent right to receive one share of common stock, and which will vest in substantially equal annual installments over a two year period following the grant date, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:45 UTC |
Skvarka JanDirector
|
PurchaseCommon Stock | 60,000 | $1.72 | $103,446.00 |
DisclosureSEC source: 0001725160-25-000030 · wk-form4_1738705494.xml · nonDerivative · entry 1 Skvarka Jan · CIK 0001838042 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 149,551 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:43 UTC |
Walker Luke NathanielDirector
|
PurchaseCommon Stock | 14,200 | $1.76 | $24,966.44 |
DisclosureSEC source: 0001725160-25-000029 · wk-form4_1738705431.xml · nonDerivative · entry 1 Walker Luke Nathaniel · CIK 0001701440 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,681 Read SEC document |
| January 31, 2025 Filed Feb 4, 2025 21:37 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
PurchaseCommon Stock | 28,500 | $1.73 | $49,344.90 |
DisclosureSEC source: 0001725160-25-000028 · wk-form4_1738705022.xml · nonDerivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,500 Read SEC document |
| January 02, 2025 Filed Jan 3, 2025 22:17 UTC |
Lackner MarkChief Scientific Officer
|
SaleCommon Stock | 4,411 | $3.12 | $13,762.32 |
DisclosureSEC source: 0001725160-25-000002 · wk-form4_1735942617.xml · nonDerivative · entry 1 Lackner Mark · CIK 0001777413 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 191,317 F1 · kind: This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of restricted stock units previously granted to the Reporting Person. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 00:02 UTC |
Bruns IngmarChief Medical Officer
|
GrantStock Option (Right to Buy) · Derivative | 712,650 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001725160-24-000190 · wk-form4_1733270555.xml · derivative · entry 1 Bruns Ingmar · CIK 0001838041 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 712,650 Underlying: Common Stock · 712,650 shares Expires 2034-12-02 F1 · derivative.exercise_date: The options will vest over a four-year period as follows: 25% of the options will vest on November 13, 2025, with the remaining 75% vesting in substantially equal monthly installments thereafter until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
| December 02, 2024 Filed Dec 4, 2024 00:02 UTC |
EASTLAND JULIA MARIEDirector · CEO & President
|
GrantStock Option (Right to Buy) · Derivative | 3,028,800 | $0.00 Strike: $3.66 | $0.00 |
DisclosureSEC source: 0001725160-24-000189 · wk-form4_1733270528.xml · derivative · entry 1 EASTLAND JULIA MARIE · CIK 0001500189 · Director · CEO & President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,028,800 Underlying: Common Stock · 3,028,800 shares Expires 2034-12-02 F1 · derivative.exercise_date: The options will vest over a four-year period following the vesting commencement date of November 13, 2024, in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.